Adam LaBonte

Adam LaBonte has a comprehensive work experience in the field of biosciences, starting from 2009 to the present. Adam is currently serving as the VP of Commercial Development at FYR Diagnostics since December 2021. Prior to this, Adam worked at Pillar Biosciences Incorporated from 2019 to 2021, where they held roles as Manager of Field Sales and Support and Sr. Field Applications Scientist.

Before joining Pillar Biosciences, Adam worked at Tecan as an Account Executive NGS from 2018 to 2019, and at QIAGEN as a Clinical NGS Field Applications Scientist-Lead from 2017 to 2018.

Adam has also gained experience at ArcherDX, Inc., where they worked as a Field Applications Scientist and later as a Research Scientist from 2014 to 2017. Prior to that, they worked as a Research Associate II at miRagen Therapuetics from 2012 to 2014, and as a Research Assistant II at Harvard Medical School/Brigham and Women's Hospital from 2010 to 2012.

Adam began their career as a Research Assistant at Plymouth State University from 2009 to 2010. Overall, Adam LaBonte has accumulated a diverse and extensive work experience in the biosciences industry.

Adam LaBonte attended Plymouth State University from 2006 to 2010, where they earned a Bachelor of Science degree in Biological Science.